C Wallrapp
Overview
Explore the profile of C Wallrapp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freimark D, Pino-Grace P, Pohl S, Weber C, Wallrapp C, Geigle P, et al.
Transfus Med Hemother
. 2010 Aug;
37(2):66-73.
PMID: 20737048
Nowadays cell-based therapy is rarely in clinical practice because of the limited availability of appropriate cells. To apply cells therapeutically, they must not cause any immune response wherefore mainly autologous...
2.
Weber C, Pohl S, Poertner R, Pino-Grace P, Freimark D, Wallrapp C, et al.
Adv Biochem Eng Biotechnol
. 2010 Jan;
123:143-62.
PMID: 20091287
Cell based therapy promises the treatment of many diseases like diabetes mellitus, Parkinson disease or stroke. Microencapsulation of the cells protects them against host-vs-graft reactions and thus enables the usage...
3.
Teller S, Kramer D, Bohmer S, Tse K, Small D, Mahboobi S, et al.
Leukemia
. 2002 Jul;
16(8):1528-34.
PMID: 12145694
Aberrant expression and activating mutations of the class III receptor tyrosine kinase Flt3 (Flk-2, STK-1) have been linked to poor prognosis in acute myeloid leukemia (AML). Inhibitors of Flt3 tyrosine...
4.
5.
Wallrapp C, Hahnel S, Boeck W, SODER A, Mincheva A, Lichter P, et al.
Int J Cancer
. 2001 Feb;
91(3):340-4.
PMID: 11169957
In a study for the identification of genomic alterations in pancreatic cancer, representational difference analysis was used and led to the isolation of 2 distinct fragments, deleted on the Y...
6.
Wallrapp C, Hahnel S, Burghardt B, Iwamura T, Ruthenburger M, Lerch M, et al.
Cancer Res
. 2000 May;
60(10):2602-6.
PMID: 10825129
We report the characterization of a novel serine protease of the chymotrypsin family, recently isolated by cDNA-representational difference analysis, as a gene overexpressed in pancreatic cancer. The 2.3-kb mRNA of...
7.
Pohl B, Wilda M, Lacher U, Beil M, Wallrapp C, Hameister H, et al.
Mech Dev
. 1999 Oct;
88(1):95-9.
PMID: 10525192
The human KOC gene which is highly expressed in cancer shows typical structural features of an RNA binding protein. We analyzed the temporal and spatial expression pattern of KOC in...
8.
Geng M, Ellenrieder V, Wallrapp C, Sommer G, Adler G, Gress T
Genes Chromosomes Cancer
. 1999 Aug;
26(1):70-9.
PMID: 10441008
It has been shown that TGFBs, their receptors, or downstream targets show genetic alterations in pancreatic cancer. This study was designed to identify transcriptional alterations induced by prolonged treatment of...
9.
Wallrapp C, Micha A, Wenger C, Geng M, Lichter P, Frohme M, et al.
Ann Oncol
. 1999 Aug;
10 Suppl 4:64-8.
PMID: 10436788
Aim: The present review summarizes our strategies aimed at identifying and characterizing genetic alterations occurring at the transcriptional and chromosomal level in pancreatic cancer. Methods: To study transcriptional alterations we...
10.
Wallrapp C, Micha A, Wenger C, Geng M, Lichter P, Frohme M, et al.
Ann N Y Acad Sci
. 1999 Jul;
880:122-46.
PMID: 10415857
The present review summarizes our strategies aimed at identifying and characterizing genetic alterations occurring at the transcriptional and chromosomal level in pancreatic cancer. To study transcriptional alterations we have used...